Literature DB >> 31546060

Inter- and Intra-assay Variation in the Diagnostic Performance of Assays for Anti-tissue Transglutaminase in 2 Populations.

Prashant Singh1, Alka Singh2, Jocelyn A Silvester3, Vikas Sachdeva2, Xinhua Chen1, Hua Xu1, Daniel A Leffler4, Vineet Ahuja2, Donald R Duerksen5, Ciaran P Kelly1, Govind K Makharia6.   

Abstract

Tissue transglutaminse-2 (TG2)-based immunoassays are the cornerstone of diagnosis in celiac disease (CeD), with a reported pooled sensitivity as high as 98%.1 However, a few small, single-center studies have questioned their sensitivity in clinical practice.2-5 Moreover, commercial kits use variable TG2 antigens,6 with cutoffs determined by using small, poorly defined populations. Variation in diagnostic performance of anti-TG2 assays in different racial and geographic populations has not yet been studied. We compared the interassay and intra-assay variations in diagnostic performance of 4 immunoglobulin (Ig)A-anti-TG2 assays in Canadian and Indian populations.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31546060      PMCID: PMC7082178          DOI: 10.1016/j.cgh.2019.09.018

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  8 in total

1.  The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of coeliac disease. Results of an international multi-centre study. International Working Group on Eu-tTG.

Authors:  E Fabiani; C Catassi
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-06       Impact factor: 2.566

2.  Autoantibodies to human tissue transglutaminase: superior predictors of coeliac disease.

Authors:  P J Blackwell; P G Hill; G K T Holmes
Journal:  Scand J Gastroenterol       Date:  2002-11       Impact factor: 2.423

3.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

4.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

Review 5.  The diagnostic accuracy of serologic tests for celiac disease: a systematic review.

Authors:  Alaa Rostom; Catherine Dubé; Ann Cranney; Navaaz Saloojee; Richmond Sy; Chantelle Garritty; Margaret Sampson; Li Zhang; Fatemeh Yazdi; Vasil Mamaladze; Irene Pan; Joanne MacNeil; David Mack; Dilip Patel; David Moher
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

6.  Sensitivity of serum tissue transglutaminase antibodies for endomysial antibody positive and negative coeliac disease.

Authors:  W Dickey; S A McMillan; D F Hughes
Journal:  Scand J Gastroenterol       Date:  2001-05       Impact factor: 2.423

7.  A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease.

Authors:  Marcella Li; Liping Yu; Claudio Tiberti; Margherita Bonamico; Iman Taki; Dongmei Miao; Joseph A Murray; Marian J Rewers; Edward J Hoffenberg; Daniel Agardh; Patricia Mueller; Martin Stern; Ezio Bonifacio; Edwin Liu
Journal:  Am J Gastroenterol       Date:  2009-01       Impact factor: 10.864

8.  Comparison of commercially available serologic kits for the detection of celiac disease.

Authors:  Afzal J Naiyer; Lincoln Hernandez; Edward J Ciaccio; Konstantinos Papadakis; John S Manavalan; Govind Bhagat; Peter H R Green
Journal:  J Clin Gastroenterol       Date:  2009-03       Impact factor: 3.062

  8 in total
  2 in total

Review 1.  The global burden of coeliac disease: opportunities and challenges.

Authors:  Govind K Makharia; Prashant Singh; Carlo Catassi; David S Sanders; Daniel Leffler; Raja Affendi Raja Ali; Julio C Bai
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-01-03       Impact factor: 46.802

Review 2.  Who to screen and how to screen for celiac disease.

Authors:  Prashant Singh; Achintya Dinesh Singh; Vineet Ahuja; Govind K Makharia
Journal:  World J Gastroenterol       Date:  2022-08-28       Impact factor: 5.374

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.